Technical competition and purchase of Semaglutide intermediates

The so-called Semaglutide intermediates are some chemical raw materials or chemical products used in the process of drug synthesis. This type of chemical product doesn't need a pharmaceutical production license and might be made in a standard manufactory. As long as it reaches a certain level, it can be used for the synthesis of pharmaceuticals. Next, let's take a look at the technical competition and purchase of Semaglutide intermediates. Here are some answers.

Here is the content list:

l Technical competition of Semaglutide intermediates.

l Choose Chengdu Pukang Biotechnology Co., Ltd to buy Semaglutide intermediates.

Technical competition of Semaglutide intermediates.

In the listing application of glycolysis customized medical-grade semaglutide intermediates, after the patent of the original drug compound expires, if the Semaglutide intermediates company can avoid the raw material drug process patent and preparation process patent of the original drug, it can initiate a patent challenge to the original drug that does not infringe its process patent declaration. After the challenge is successful, it will realize the advanced sales of generic drugs before the expiration of the original research drug process patent, and obtain market exclusivity, thereby obtaining high returns and market share. Taking the US pharmaceutical market as an example, if a lab synthesized long-acting semaglutide intermediates company is the first to submit an ANDA and can prove that the patent of the target brand drug is invalid or its Api stable 98% semaglutide intermediates do not constitute an infringement of the patent (that is, a PIV statement), it can Successfully challenge the target drug, obtained a valuable 180-day market exclusivity period, took the lead in occupying the generic drug market, and could be sold at 70%-80% of the price of the patented drug; and later, the price of the drug may drop to 30% of the patented drug- Around 50%. Therefore, robbing the first generic is crucial for generic drug companies. However, the technical barriers to avoiding API process patents are relatively high, and there are not many API companies that can challenge API process patents. If API companies can successfully challenge API process patents, and cooperate with downstream generic drug companies to challenge original research After the first imitation of the pharmaceutical process patent is achieved, it can share the huge benefits brought by the first imitation with downstream generic drug companies.

Choose Chengdu Pukang Biotechnology Co., Ltd to buy Semaglutide intermediates.

At present, large pharmaceutical companies are more focused on improving their core competitiveness, focusing on the R&D and sales of Semaglutide. To shorten the cycle of recent drug R&D and scale back the value of recent drug R&D, they typically source custom production of intermediates. Some companies provide customized intermediate synthesis services. Chengdu Pukang Biotechnology Co., Ltd provides customized synthesis services for pharmaceutical high purity powder semaglutide intermediates, which can synthesize reference compounds, intermediates, candidate drugs, impurities and metabolites, and other small molecule chemical substances for customers. The scale can range from milligrams to milligrams. The team is proficient in new route design and route optimization, relying on proficient problem-solving skills and a high success rate of projects.

Our official website is https://www.pu-kang.com/. For more questions about Semaglutide intermediates, please consult us. Years of accumulated R&D and production experience will provide you with more product services and technical support!